There is clearly a time element to all of this. But if they're going to pursue TBI with a larger TAM, than great. I'm in it for the long haul.
- Forums
- ASX - By Stock
- Ann: Phase III Clinical Trial Update and New IIH Market Analysis
IXC
invex therapeutics ltd
Add to My Watchlist
0.00%
!
8.9¢

There is clearly a time element to all of this. But if they're...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.688M |
Open | High | Low | Value | Volume |
8.9¢ | 8.9¢ | 8.9¢ | $79 | 893 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 41290 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 41290 | 0.088 |
1 | 42086 | 0.083 |
1 | 40000 | 0.075 |
1 | 14285 | 0.070 |
1 | 16666 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 9000 | 1 |
0.099 | 21180 | 1 |
0.105 | 50000 | 1 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
Last trade - 11.13am 30/06/2025 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online